Impact of changes to policy for Mexican risk travel on Canadian blood donor deferrals

Blood Transfusion

Volumn 11, Issue 4, 2013, Pages 580-584

  O'Brien, Sheila F ^a,b   Uzicanin, Samra ^b   Choquet, Karine ^b   Yi, Qi Long ^a,b   Fan, Wenli ^b   Goldman, Mindy ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

Author keywords

Blood safety; Donor deferral; Malaria; Quintana Roo

Indexed keywords

ARTICLE; BLOOD BANK; BLOOD DONOR; BLOOD SAFETY; CANADA; CENTRAL AMERICA; CONTROLLED STUDY; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MEXICO; NORMAL HUMAN; RISK ASSESSMENT; SEA; SEASONAL VARIATION; SUMMER; TRAVEL; TREND STUDY; WINTER;

BLOOD DONORS; CANADA; DONOR SELECTION; FEMALE; HUMANS; MALARIA; MALE; MEXICO; RISK FACTORS; TRAVEL;

EID: 84891954039     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2013.0261-12     Document Type: Article

References (16)

1. O'Brien SF, Ram SS, Vamvakas EC, Goldman M. The Canadian blood donor health assessment questionnaire: lessons from history, application of cognitive science principles, and recommendations for change. Transfus Med Rev 2007; 21: 205-22.
2. O'Brien SF, Chiavetta JA, Goldman M, et al. Predictive ability of sequential surveys in determining donor loss from increasingly stringent variant Creutzfeldt-Jakob disease deferral policies. Transfusion 2006; 46: 461-8.
3. Leiby DA, Nguyen ML, Notari EP. Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008; 48: 2222-8.
4. O'Brien SF, Fan W, Xi G, et al. Donor loss due to malaria-risk travel deferral. Transfusion 2008: 48 (2S); 62A.
5. World Health Organization. World malaria report 2011 Available at: http://www.who.int /malaria/world-malaria-report-2011/en/. Accessed on 09/01/2013.
6. Spencer B, Steele W, Custer B, et al. Risk of malaria in United States donors deferred for travel to malaria-endemic areas. Transfusion 2009; 49: 2335-45.
7. Spencer B, Kleinman S, Custer B, et al. Deconstructing the risk for malaria in United States donors deferred for travel to Mexico. Transfusion 2011; 51; 2398-410.
8. Guidance for industry. Recommendations for donor questioning, deferral, re-entry and product management to reduce the risk of transfusion-transmitted malaria. Food and Drug Administration. Available at: http://www.fda.gov/ BiologicsBloodVaccines/GuidanceComplianceRegulatory Information/Guidances/Blood/ ucm077061.htm. Accessed on 28/08/2012.
9. Travel by Canadians to foreign countries. Statistics Canada. Available at: http://www.statcan.gc.ca/tables-tableaux/sumsom/l01/cst01/arts37a-eng.htm. Accessed on 28/09/2012.
10. Slinger R, Giulivi A, Bodie-Collins M, et al. Transfusiontransmitted malaria in Canada. Can Med Assoc J 2001; 164: 377-9.
11. Mungai M, Tegtmeir G, Chamberland M, Parise M. Transfusion-transmitted malaria in the United States from 1963 through 1999. N Engl J Med 2001; 344: 1973-8.
12. Mali S, Kachur SP Arguin PM. Malaria Surveillance - 2010. MMWR 2012; 61: 1-18.
13. Mali S, Kachur SP Arguin PM. Malaria Surveillance - 2009. MMWR 2011; 60: 1-15.
14. Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sang 2006; 90: 77-84.
15. Seed CR, Cheng A, Davis TM, et al. The efficacy of a malarial antibody enzyme immunoassay for establishing the reinstatement status of blood donors potentially exposed to malaria. Vox Sang 2005; 88: 98-106.
16. Reesink HW, Panzer S, Wendel S, et al. The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang 2010; 98: 468-78.